According to diabetes news reports, cannabis could be used to create a market-leading diabetes treatment, according to a lauded scientist. Professor Mark Cawthorne, who headed up a team that developed GlaxoSmithKline’s Avandia, said that plant-based medicine was the future.
Speaking to Reuters, Cawthorne reportedly commented: “I sincerely believe it is possible to improve on it (Avandia), and plant-based medicines could be one way to do that.”
At this stage, Cawthorne is working closely with GW Pharma, experts in developing cannabis-based medicine. At the GW Metabolic Research Laboratory, different cannabinoid molecules will be examined, alongside a range of other plants.
Cannabis has a complex relationship with medicine. Although there are obvious beneficial properties of the plant, there have also been concerns over side effects . Cawthorne is working with actual cannabis extract.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…